HomeNewsIndiaFree COVID-19 vaccines: Centre to provide 25% jabs to states based on population, disease burden, inoculation progress

Free COVID-19 vaccines: Centre to provide 25% jabs to states based on population, disease burden, inoculation progress

States and UTs would aggregate the demand of private hospitals keeping in view equitable distribution between large and small private hospitals and regional balance.

June 08, 2021 / 12:50 IST
Story continues below Advertisement
Based on aggregate demand, the Centre will facilitate supply of these vaccines to the private hospitals(Representative image)
Based on aggregate demand, the Centre will facilitate supply of these vaccines to the private hospitals(Representative image)

The Central government said on June 8 that 25 percent vaccine doses would be provided free of cost to the states and Union Territories, based on criteria such as population, disease burden and the progress of vaccination.

Within the population group of citizens more than 18 years of age, States and UTs may decide their own prioritization factoring in the vaccine supply schedule, according to the Revised Guidelines of Implementation of National COVID Vaccination Programme announced on June 8.

Story continues below Advertisement

The priority will be Health Care Workers or Front Line Workers, citizens more than 45 years of age, citizens whose second dose has become due and people of 18 years & above. All citizens irrespective of their income status are entitled to free vaccination. Those who have the ability to pay are encouraged to use private hospital’s vaccination centres.

Wastage of vaccines will affect the allocation negatively.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show